MTOR and autoimmune disease: Overall, contemporary research reviewed [52] indicates that mTOR signaling activation is a positive regulator for the differentiation of CD4+ effector T cells and a negative regulator for Treg differentiation, and dysregulated mTOR signaling is involved in a number of autoimmune diseases.